Published in JAMA on January 09, 2008
A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med (2013) 5.52
The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull (2009) 3.78
Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder. Am J Psychiatry (2013) 3.69
Metformin and other biguanides in oncology: advancing the research agenda. Cancer Prev Res (Phila) (2010) 2.60
Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomes. Am J Psychiatry (2014) 1.94
Inequalities in healthcare provision for people with severe mental illness. J Psychopharmacol (2010) 1.93
A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP). Am J Psychiatry (2011) 1.87
Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis. Schizophr Bull (2014) 1.60
Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis. Neuropsychopharmacology (2010) 1.54
Exercise therapy for schizophrenia. Cochrane Database Syst Rev (2010) 1.45
Metformin: an old but still the best treatment for type 2 diabetes. Diabetol Metab Syndr (2013) 1.31
Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review. Schizophr Bull (2015) 1.21
Association of psychiatric illness and obesity, physical inactivity, and smoking among a national sample of veterans. Psychosomatics (2011) 1.20
Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms. Anesthesiology (2008) 1.19
Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability. J Child Adolesc Psychopharmacol (2010) 1.15
Pharmacogenetics in psychiatry: translating research into clinical practice. Mol Psychiatry (2011) 1.13
The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study. Fertil Steril (2010) 1.09
Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: a systematic review. Int J Behav Nutr Phys Act (2011) 1.08
The James Mackenzie Lecture 2012: bothering about Billy. Br J Gen Pract (2013) 1.08
Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers. Curr Psychiatry Rev (2012) 1.08
Management of antipsychotic-related weight gain. Expert Rev Neurother (2010) 1.07
Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis. Br J Clin Pharmacol (2011) 0.98
FoxO1 controls lysosomal acid lipase in adipocytes: implication of lipophagy during nutrient restriction and metformin treatment. Cell Death Dis (2013) 0.93
Obesity in children with autism spectrum disorder. Harv Rev Psychiatry (2014) 0.89
Antipsychotic-induced weight gain in patients with schizophrenia. JAMA (2008) 0.88
Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study. Biol Psychiatry (2009) 0.87
Short-term nutritional counseling reduces body mass index, waist circumference, triceps skinfold and triglycerides in women with metabolic syndrome. Diabetol Metab Syndr (2010) 0.86
Managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approach. J Multidiscip Healthc (2014) 0.86
Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention. Drugs (2015) 0.86
Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis. BMC Psychiatry (2009) 0.85
Double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder. J Res Med Sci (2015) 0.85
Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials. Mol Psychiatry (2016) 0.85
Efficacy of lifestyle interventions in physical health management of patients with severe mental illness. Ann Gen Psychiatry (2011) 0.84
Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs. Front Psychiatry (2012) 0.83
The effects of lifestyle interventions on (long-term) weight management, cardiometabolic risk and depressive symptoms in people with psychotic disorders: a meta-analysis. PLoS One (2014) 0.83
A randomized controlled trial undertaken to test a nurse-led weight management and exercise intervention designed for people with serious mental illness who take second generation antipsychotics. J Adv Nurs (2012) 0.82
Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits. BMC Med (2012) 0.81
Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis. BMC Psychiatry (2016) 0.81
Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.80
A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia. BMC Psychiatry (2013) 0.80
Interventions for the metabolic syndrome in schizophrenia: a review. Ther Adv Endocrinol Metab (2012) 0.80
Metabolic syndrome in bipolar disorders. Indian J Psychol Med (2012) 0.79
The effectiveness of lifestyle interventions to reduce cardiovascular risk in patients with severe mental disorders: meta-analysis of intervention studies. Community Ment Health J (2013) 0.78
Behavioral interventions for antipsychotic induced appetite changes. Curr Psychiatry Rep (2013) 0.78
A role for hypothalamic AMP-activated protein kinase in the mediation of hyperphagia and weight gain induced by chronic treatment with olanzapine in female rats. Cell Mol Neurobiol (2011) 0.78
Psychological and psychiatric aspects of treatment of obesity and nonalcoholic fatty liver disease. Clin Liver Dis (2012) 0.77
Improving dietary and physical activity practices in group homes serving residents with severe mental illness. Prog Community Health Partnersh (2010) 0.76
Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study. Neuropsychiatr Dis Treat (2015) 0.76
Perceptions and dietary intake of self-described healthy and unhealthy eaters with severe mental illness. Community Ment Health J (2014) 0.76
Metformin plus a lifestyle intervention was more effective than either alone for antipsychotic-induced weight gain. ACP J Club (2008) 0.75
Lithium or Valproate Adjunctive Therapy to Second-generation Antipsychotics and Metabolic Variables in Patients With Schizophrenia or Schizoaffective Disorder. J Psychiatr Pract (2016) 0.75
Can metformin undo weight gain induced by antipsychotics? J Fam Pract (2008) 0.75
The Effectiveness of Pharmacological and Non-Pharmacological Interventions for Improving Glycaemic Control in Adults with Severe Mental Illness: A Systematic Review and Meta-Analysis. PLoS One (2017) 0.75
Commentary: A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin Treatment of Weight Gain Associated with Initiation of Atypical Antipsychotic Therapy in Children and Adolescents. Front Psychiatry (2017) 0.75
Metformin for treatment of clozapine-induced weight gain in adult patients with schizophrenia: a meta-analysis. Shanghai Arch Psychiatry (2015) 0.75
Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study. PLoS One (2016) 0.75
Diabetes and glucose disturbances in patients with psychosis in Sweden. BMJ Open Diabetes Res Care (2015) 0.75
Weight Gain and Its Correlates Among Forensic Inpatients. Can J Psychiatry (2015) 0.75
Effect of nutritional counseling and long term isomaltulose based liquid formula (MHN-01) intake on metabolic syndrome. J Clin Biochem Nutr (2015) 0.75
The Impact of a 24 Month Housing First Intervention on Participants' Body Mass Index and Waist Circumference: Results from the At Home / Chez Soi Toronto Site Randomized Controlled Trial. PLoS One (2015) 0.75
A case of successful treatment of comorbid obesity and polycystic ovarian disease with add-on metformin in bipolar disorder. Prim Care Companion CNS Disord (2011) 0.75
Effect of Metformin on Different Non-Diabetes Related Conditions, a Special Focus on Malignant Conditions: Review of Literature. J Clin Med Res (2017) 0.75
Antipsychotic-induced weight gain in patients with schizophrenia. JAMA (2008) 0.75
Metformin: prevention and treatment of antipsychotic-induced weight gain. Hosp Pharm (2013) 0.75
Metformin and lifestyle changes reduce antipsychotic-related weight gain in adults with schizophrenia. Evid Based Ment Health (2008) 0.75
Adjuvant metformin worsens psychosis in schizophrenia: a case report. Prim Care Companion J Clin Psychiatry (2010) 0.75
An overview of diabetes management in schizophrenia patients: office based strategies for primary care practitioners and endocrinologists. Int J Endocrinol (2015) 0.75
Screening for MRSA at hospital admission. Am J Nurs (2008) 0.75
Metformin plus a lifestyle intervention was more effective than either alone for antipsychotic-induced weight gain. Evid Based Med (2008) 0.75
Loxapine for Reversal of Antipsychotic-Induced Metabolic Disturbances: A Chart Review. J Autism Dev Disord (2016) 0.75
The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev (2004) 11.58
A septin diffusion barrier at the base of the primary cilium maintains ciliary membrane protein distribution. Science (2010) 4.11
Trafficking to the ciliary membrane: how to get across the periciliary diffusion barrier? Annu Rev Cell Dev Biol (2010) 3.38
Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nat Chem Biol (2006) 3.30
T2 relaxation time of cartilage at MR imaging: comparison with severity of knee osteoarthritis. Radiology (2004) 3.24
Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study. Am J Psychiatry (2008) 2.69
Diffusion tensor imaging: serial quantitation of white matter tract maturity in premature newborns. Neuroimage (2004) 2.58
Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K. Cell (2009) 2.39
The radish Rfo restorer gene of Ogura cytoplasmic male sterility encodes a protein with multiple pentatricopeptide repeats. Plant J (2003) 2.03
Risperidone maintenance treatment in schizophrenia: a randomized, controlled trial. Am J Psychiatry (2010) 1.94
A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res (2006) 1.94
Effect of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia: A randomized, 1-year study. Arch Gen Psychiatry (2010) 1.89
Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study. Am J Psychiatry (2012) 1.85
Multiple mechanism-mediated retention of a defective brassinosteroid receptor in the endoplasmic reticulum of Arabidopsis. Plant Cell (2008) 1.79
Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. AIDS (2010) 1.66
Regulation of brassinosteroid signaling. Trends Plant Sci (2006) 1.65
Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neurovirol (2008) 1.64
A design of phase II cancer trials using total and complete response endpoints. Stat Med (2005) 1.60
Phosphorylation stabilizes Nanog by promoting its interaction with Pin1. Proc Natl Acad Sci U S A (2010) 1.57
A pilot, two-year longitudinal study of the interrelationship between trabecular bone and articular cartilage in the osteoarthritic knee. Osteoarthritis Cartilage (2004) 1.41
Comparing microstructural and macrostructural development of the cerebral cortex in premature newborns: diffusion tensor imaging versus cortical gyration. Neuroimage (2005) 1.36
Gestational diabetes mellitus in women of single gravidity in Tianjin City, China. Diabetes Care (2002) 1.23
Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia. Psychopharmacology (Berl) (2006) 1.19
Successful aging in Shanghai, China: definition, distribution and related factors. Int Psychogeriatr (2006) 1.18
DNA microarray reveals that high proportions of human blastocysts from women of advanced maternal age are aneuploid and mosaic. Biol Reprod (2012) 1.18
Multiplex targeting, tracking, and imaging of apoptosis by fluorescent surface enhanced Raman spectroscopic dots. Bioconjug Chem (2007) 1.17
Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas. NMR Biomed (2004) 1.17
The 100 top-cited articles in orthodontics from 1975 to 2011. Angle Orthod (2012) 1.16
Magnetic resonance evaluation of the interrelationship between articular cartilage and trabecular bone of the osteoarthritic knee. Osteoarthritis Cartilage (2004) 1.14
Mutations of an alpha1,6 mannosyltransferase inhibit endoplasmic reticulum-associated degradation of defective brassinosteroid receptors in Arabidopsis. Plant Cell (2009) 1.14
Induction of cell retraction by the combined actions of Abl-CrkII and Rho-ROCK1 signaling. J Cell Biol (2008) 1.13
Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study. J Int Neuropsychol Soc (2007) 1.12
APOE epsilon4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors. AIDS (2010) 1.12
The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia. Biol Psychiatry (2008) 1.11
Body distribution of inhaled fluorescent magnetic nanoparticles in the mice. J Occup Health (2008) 1.10
Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes. J Endocrinol (2008) 1.08
Giant mesenteric hemangioma of cavernous and venous mixed type: a rare case report. BMC Surg (2013) 1.07
The kyphoscoliotic type of Ehlers-Danlos syndrome (type VI): differential effects on the hydroxylation of lysine in collagens I and II revealed by analysis of cross-linked telopeptides from urine. Mol Genet Metab (2002) 1.05
Altered resting-state functional connectivity of thalamus in earthquake-induced posttraumatic stress disorder: a functional magnetic resonance imaging study. Brain Res (2011) 1.02
Ginsenoside Rb1 promotes adipogenesis in 3T3-L1 cells by enhancing PPARgamma2 and C/EBPalpha gene expression. Life Sci (2006) 1.00
PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells. J Clin Invest (2017) 0.98
Chondroitin sulfate extracted from the Styela clava tunic suppresses TNF-alpha-induced expression of inflammatory factors, VCAM-1 and iNOS by blocking Akt/NF-kappaB signal in JB6 cells. Cancer Lett (2008) 0.97
Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells. Mol Cancer Ther (2006) 0.97
From chain to network: design and analysis of novel organic-inorganic assemblies from organically functionalized zinc-substituted polyoxovanadates and zinc organoamine subunits. Inorg Chem (2007) 0.96
Roles of protein kinase B/Akt in lung cancer. Front Biosci (Elite Ed) (2010) 0.96
Poly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis. Am J Respir Crit Care Med (2008) 0.96
Evolutionarily conserved glycan signal to degrade aberrant brassinosteroid receptors in Arabidopsis. Proc Natl Acad Sci U S A (2012) 0.96
Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells. J Vet Sci (2009) 0.95
Identifying cancer-related genes in nasopharyngeal carcinoma cell lines using DNA and mRNA expression profiling analyses. Int J Oncol (2002) 0.94
Warm temperatures induce transgenerational epigenetic release of RNA silencing by inhibiting siRNA biogenesis in Arabidopsis. Proc Natl Acad Sci U S A (2013) 0.93
Emodin with PPARgamma ligand-binding activity promotes adipocyte differentiation and increases glucose uptake in 3T3-Ll cells. Biochem Biophys Res Commun (2006) 0.92
Efficacy and safety of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, randomized, double-blind, flexible-dose study. Psychopharmacology (Berl) (2010) 0.91
Bipolar disorder in middle-aged and elderly adults: is age of onset important? J Nerv Ment Dis (2004) 0.91
Decreased left middle temporal gyrus volume in antipsychotic drug-naive, first-episode schizophrenia patients and their healthy unaffected siblings. Schizophr Res (2013) 0.91
Subtype-specific roles of cAMP phosphodiesterases in regulation of atrial natriuretic peptide release. Eur J Pharmacol (2002) 0.91
On the non-inferiority of a diagnostic test based on paired observations. Stat Med (2003) 0.91
Altered resting brain function and structure in professional badminton players. Brain Connect (2012) 0.90
Sex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia. J Clin Psychopharmacol (2007) 0.89
Neurocognitive effects of first- and second-generation antipsychotic drugs in early-stage schizophrenia: a naturalistic 12-month follow-up study. Neurosci Lett (2011) 0.89
Altered regional homogeneity in post-traumatic stress disorder: a resting-state functional magnetic resonance imaging study. Neurosci Bull (2012) 0.88
Metabolic syndrome: relative risk associated with post-traumatic stress disorder (PTSD) severity and antipsychotic medication use. Psychosomatics (2012) 0.88
Higher frequency of peripheral blood interleukin 21 positive follicular helper T cells in patients with ankylosing spondylitis. J Rheumatol (2013) 0.87
Anti-tumor activity evaluation of novel chrysin-organogermanium(IV) complex in MCF-7 cells. Bioorg Med Chem Lett (2013) 0.87
Socio-demographic and clinical determinants of quality of life in Chinese patients with schizophrenia: a prospective study. Qual Life Res (2010) 0.86
Preservation of superhydrophobic and superoleophobic properties upon wear damage. ACS Appl Mater Interfaces (2013) 0.86
Odor and gas release from anaerobic treatment lagoons for swine manure. J Environ Qual (2003) 0.86
[Change in intestinal function in sepsis in rat]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue (2004) 0.86
Sulforaphane protects against 6-hydroxydopamine-induced cytotoxicity by increasing expression of heme oxygenase-1 in a PI3K/Akt-dependent manner. Mol Med Rep (2011) 0.86
Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study. Diagn Pathol (2013) 0.86
Potential mechanisms of atypical antipsychotic-induced hypertriglyceridemia. Psychopharmacology (Berl) (2013) 0.85
Neuropsychological performance in mainland china: the effect of urban/rural residence and self-reported daily academic skill use. J Int Neuropsychol Soc (2010) 0.85
Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells. Mol Cell Biochem (2012) 0.85
Morphology and mechanics of chondroid cells from human adipose-derived Stem cells detected by atomic force microscopy. Mol Cell Biochem (2012) 0.85
Discontinuation of quetiapine from an NIMH-funded trial due to serious adverse events. Am J Psychiatry (2009) 0.85
Intensive diabetes management may improve pregnancy: outcomes in Chinese gravidas with impaired glucose tolerance. Diabetes Care (2003) 0.85
Selenium nanoparticles induced membrane bio-mechanical property changes in MCF-7 cells by disturbing membrane molecules and F-actin. Bioorg Med Chem Lett (2013) 0.84
The characterization of small hypoattenuating renal masses on contrast-enhanced CT. Clin Imaging (2009) 0.84
[Application of amplitude of low-frequency fluctuation to the temporal lobe epilepsy with bilateral hippocampal sclerosis: an fMRI study]. Zhonghua Yi Xue Za Zhi (2008) 0.84
Cloning, expression and characterisation of a human Nudix hydrolase specific for adenosine 5'-diphosphoribose (ADP-ribose). Biochim Biophys Acta (2002) 0.84
Constant or fluctuating hyperglycemias increases cytomembrane stiffness of human umbilical vein endothelial cells in culture: roles of cytoskeletal rearrangement and nitric oxide synthesis. BMC Cell Biol (2013) 0.83
Psychiatric context of human immunodeficiency virus infection among former plasma donors in rural China. J Affect Disord (2010) 0.83
Insulin-producing cells from human adipose tissue-derived mesenchymal stem cells detected by atomic force microscope. Appl Microbiol Biotechnol (2012) 0.83
Cinobufacini induced MDA-MB-231 cell apoptosis-associated cell cycle arrest and cytoskeleton function. Bioorg Med Chem Lett (2011) 0.83
Curcumin disturbed cell-cycle distribution of HepG2 cells via cytoskeletal arrangement. Scanning (2012) 0.83
Synergistic anti-tumor activity of paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel in vitro and in vivo. Biomaterials (2009) 0.83
Sex differences in patients with schizophrenia: A prospective, multi-center study. Psychiatry Res (2010) 0.82
MiR-34c inhibits osteosarcoma metastasis and chemoresistance. Med Oncol (2014) 0.82
Low dietary inorganic phosphate stimulates lung tumorigenesis through altering protein translation and cell cycle in K-ras(LA1) mice. Nutr Cancer (2010) 0.82